-

SHAREHOLDER ALERT: Robbins LLP Announces that Waterdrop Inc. (WDH) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a shareholder filed a class action on behalf of all persons and entities that purchased Waterdrop Inc. (NYSE: WDH) American Depository Shares ("ADSs") in or traceable to the Company's May 2021 initial public offering ("IPO"). The complaint seeks remedies pursuant to the Securities Act of 1933. Waterdrop operates an insurance technology platform purportedly focused on providing "a positive social impact."

If you suffered a loss due to Waterdrop Inc.'s misconduct, click here.

Waterdrop Inc. (WDH) Materially Misrepresented its Revenue Growth and Increased Customer Base in its IPO Documents

According to the complaint, leading up to the IPO, Waterdrop claimed it was experiencing tremendous revenue growth, stating that its gross revenue increased by over 100% between 2019 and 2020. Further, the documents supporting the IPO stated that Waterdrop had "achieved exponential growth since [its] inception" and was poised to take advantage of a massive market opportunity among under-insured Chinese communities. The IPO documents also stated that Waterdrop's customer base increased nearly eight-fold between 2018 and 2020.

However, defendants failed to disclose that Waterdrop was the subject of an intense regulatory investigation and pending crackdown by Chinese authorities because of a variety of market abuses perpetrated by the Company, which artificially inflated Waterdrop's short-term financial results in the lead up to the IPO. Specifically, Waterdrop operated insurance platforms without proper governmental authorizations, mispriced risks for customers, and illicitly used client information. Further, Waterdrop had suffered rapidly accelerating operating losses in the first quarter of 2021, completed weeks before the IPO.

On June 17, 2021, Waterdrop announced the Company's financial results for the quarter ended March 31, 2021, the quarter before the IPO. The Company reported that its operating costs and expenses had ballooned over 75% to RMB1,343.9 million. As a result, the Company suffered an operating loss for the quarter of RMB460.6 million, compared with an operating loss of RMB111.1 million for the same period of 2020 – a more than four-fold increase.

On August 11, 2021, multiple news sources reported that China's banking and insurance watchdog, the China Banking and Insurance Regulatory Commission, had issued an order directing insurance companies, including Waterdrop, to cease improper marketing and pricing practices rampant in the industry and enhance their user privacy protections. On September 8, 2021, Waterdrop announced its financial results for the quarter ended June 30, 2021, noting that operating losses had continued to accelerate due to a sharp increase in the Company's costs and operating expenses. On September 13, 2021, Waterdrop ADSs dropped to a low of $3 per share, losing 75% of the value at which it was sold to the investing public.

If you purchased shares of Waterdrop Inc. (WDH) ADSs in or traceable to the Company's May 21, 2021 IPO, you have until November 15, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Waterdrop Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Urges GOSS Stockholders to Contact the Firm for Information About the Class Action Against Gossamer Bio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) associated with interstitial lung disease.For more information, submit a form, email att...

Robbins LLP Urges IBRX Stockholders to Contact the Firm for Information About the Class Action Against ImmunityBio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? January 19, 2026 – March 25, 202...

Robbins LLP Reminds ALDX Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Case Against Aldeyra Therapeutics, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) securities between November 3, 2023 and March 16, 2026. Defendant Aldeyra describes itself as a “biotechnology company devoted to discovering innovative therapies designed to treat immune-mediated diseases.” Pertinent to this action is reproxalap, which is a novel reactive aldehyde species (RASP) inhib...
Back to Newsroom